TLR4 and Alzheimer disease: Among them, toll-like receptors (TLRs), especially TLR4, can promote inflammatory response by activating downstream nuclear factor kappa-B (NF-κB), and promote microglia to polarize towards the M1 phenotype, thereby aggravating AD pathology 14.